EverSource Wealth Advisors LLC Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

EverSource Wealth Advisors LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 24.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,606 shares of the healthcare conglomerate’s stock after acquiring an additional 719 shares during the period. EverSource Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,824,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.0 %

UNH stock opened at $481.18 on Thursday. The company has a market cap of $440.14 billion, a price-to-earnings ratio of 31.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a fifty day moving average price of $512.33 and a 200 day moving average price of $551.50.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.75%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on UNH. Barclays lowered their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.